Ataxia-telangiectasia (A-T) is a rare, inherited disorder that affects the nervous system, immune system, and other body systems. It is caused by a mutation in the ATM gene, which is found on chromosome 11. The ATM gene helps regulate cell division and is involved in the repair of damaged DNA. People with A-T have a defective form of the ATM gene, which results in an increased risk of developing cancer.
Symptoms of Ataxia-Telangiectasia
Ataxia-telangiectasia typically presents in early childhood with progressive difficulty in walking, poor muscle coordination (ataxia), and telangiectasia (dilated small blood vessels) of the eyes, face, and ears. Other symptoms can include:
• Reduced immunity, leading to frequent infections
• Delayed growth and development
• Slowed speech
• Problems with balance and coordination
• Slow eye movements
• High risk of certain types of cancer
The Role of DNA in Ataxia-Telangiectasia
A-T is caused by a mutation in the ATM gene. This gene is responsible for producing a protein that helps regulate cell division and repair damaged DNA. The mutation results in the production of an abnormal form of the protein, which leads to damage to the cells and an increased risk of developing cancer.
The ATM gene is found on chromosome 11, and the mutation is passed down from parent to child. People who have inherited the mutation have a 50% chance of passing it on to their children.
Diagnosis and Treatment of Ataxia-Telangiectasia
Ataxia-telangiectasia is diagnosed through genetic testing. A blood sample is taken, and the defective gene is identified. Treatment for the disorder focuses on managing the symptoms and preventing complications. Physical therapy, occupational therapy, and speech therapy can help improve motor skills and communication. Medications can also be used to manage symptoms and reduce the risk of infections. Patients should also be monitored for cancer, as they are more likely to develop certain types of cancer.